Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Wiestner

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|July 7, 2018
Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapyAlankrita Taneja, Jade Jones, Stefania Pittaluga, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2018
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1Junpeng Qi, Xiuling Li, Haiyong Peng, et al.
American Journal of Hematology|August 4, 2011
Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemiaGeorg Aue, Jay Nelson Lozier, Xin Tian, et al.
Academic Radiology|July 22, 2022
Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic LeukemiaOlanrewaju A Ogunleye, Li-Yueh Hsu, Clare C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell linesAna I Robles, Mollie H Wright, Bheru Gandhi, et al.
British Journal of Haematology|November 11, 2022
Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemiaShira R Paul, Douglas R Rosing, Mark C Haigney, et al.
Leukemia & Lymphoma|July 31, 2012
Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemiaPeixuan Zhu, Heba A Degheidy, Gerald E Marti, et al.
Leukemia & Lymphoma|April 10, 2008
Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathwaysEdgar Gil Rizzatti, Helena Mora-Jensen, Marc Andrée Weniger, et al.
British Journal of Haematology|March 6, 2010
Unexpected detection of monoclonal B-cell lymphocytosis in a HLA-matched sibling donor on the day of allogeneic stem cell transplantation for a patient with chronic lymphocytic leukaemia: clinical outcomeYair Herishanu, Rinat Eshel, Sigi Kay, et al.
Haematologica|August 15, 2009
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemiaGeorg Aue, Margaret A Lindorfer, Paul V Beum, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|July 7, 2018
Richter transformation to Hodgkin lymphoma on Bruton's tyrosine kinase inhibitor therapyAlankrita Taneja, Jade Jones, Stefania Pittaluga, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2018
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1Junpeng Qi, Xiuling Li, Haiyong Peng, et al.
American Journal of Hematology|August 4, 2011
Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemiaGeorg Aue, Jay Nelson Lozier, Xin Tian, et al.
Academic Radiology|July 22, 2022
Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic LeukemiaOlanrewaju A Ogunleye, Li-Yueh Hsu, Clare C Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Schedule-dependent synergy between the heat shock protein 90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin and doxorubicin restores apoptosis to p53-mutant lymphoma cell linesAna I Robles, Mollie H Wright, Bheru Gandhi, et al.
British Journal of Haematology|November 11, 2022
Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemiaShira R Paul, Douglas R Rosing, Mark C Haigney, et al.
Leukemia & Lymphoma|July 31, 2012
Quantitative detection of zeta-chain-associated protein 70 expression in chronic lymphocytic leukemiaPeixuan Zhu, Heba A Degheidy, Gerald E Marti, et al.
Leukemia & Lymphoma|April 10, 2008
Noxa mediates bortezomib induced apoptosis in both sensitive and intrinsically resistant mantle cell lymphoma cells and this effect is independent of constitutive activity of the AKT and NF-kappaB pathwaysEdgar Gil Rizzatti, Helena Mora-Jensen, Marc Andrée Weniger, et al.
British Journal of Haematology|March 6, 2010
Unexpected detection of monoclonal B-cell lymphocytosis in a HLA-matched sibling donor on the day of allogeneic stem cell transplantation for a patient with chronic lymphocytic leukaemia: clinical outcomeYair Herishanu, Rinat Eshel, Sigi Kay, et al.
Haematologica|August 15, 2009
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemiaGeorg Aue, Margaret A Lindorfer, Paul V Beum, et al.
Pageof 19